Changes secondary to lack of flow rather than hypoxia play a major role in ischemic damage to the sarcolemmal membrane, which is not exacerbated by short-term reperfusion.
Answers are grounded in this paper and cite their sources.
Flow cessation, not hypoxia, drives sarcolemmal injury; leaves open ion-transport targeting in human ischemia.
Isolated spontaneously beating rat hearts were perfused in the Langendorff mode and divided into four groups, i.e., control (aerobic), hypoxic (95% N2-5% CO2), ischemic, and ischemic reperfused. After a total of 90 min of perfusion, the sarcolemma was isolated and enzymatically characterized. Ouabain-sensitive Na+-K+-ATPase was inhibited in all three experimental groups, whereas K+-stimulated phosphatase activity was decreased only in the ischemic and reperfused groups compared with control. 5'-Nucleotidase activity was inhibited (P less than 0.05) only in the ischemic group. Mg2+-ATPase activity was not different from control. Passive Ca2+ uptake and Ca2+ efflux were not significantly altered by any of the interventions. Na+-Ca2+ exchange rate, but not capacity, was decreased (by 32-42%) in the ischemic group but this was partially reversed on reperfusion. These results suggest that changes secondary to lack of flow rather than O2 play a major role in the etiology of ischemic damage to the membrane and that a 15-min period of reperfusion after 60 min of ischemia does not exacerbate this damage.
No takes yet. Share an insight, caveat, or question.
Daly et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: